Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome

Circulation: Cardiovascular Genetics

Volumn 6, Issue 4, 2013, Pages 354-361

  Duchatelet, Sabine ^a   Crotti, Lia ^b,c,d   Peat, Rachel A ^a   Denjoy, Isabelle ^a,e   Itoh, Hideki ^f   Berthet, Myriam ^a   Ohno, Seiko ^g   Fressart, Véronique ^h   Monti, Maria Cristina ^b   Crocamo, Cristina ^b   Pedrazzini, Matteo ^c   Dagradi, Federica ^b,c   Vicentini, Alessandro ^b   Klug, Didier ⁱ   Brink, Paul A ^j   Goosen, Althea ^j   Swan, Heikki ^k   Toivonen, Lauri ^k   Lahtinen, Annukka M ^k   Kontula, Kimmo ^k   Shimizu, Wataru ^l   Horie, Minoru ^f   George Jr , Alfred L ^m   Trégouët, David Alexandre ^a,n   Guicheney, Pascale ^a   Schwartz, Peter J ^b,c,o,p   more..

^a SORBONNE UNIVERSITÉ   (France)

^b UNIVERSITY OF PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e BICHAT HOSPITAL   (France)

^f SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^g KYOTO UNIVERSITY   (Japan)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ UNIV LILLE   (France)

^j STELLENBOSCH UNIVERSITY   (South Africa)

^k UNIVERSITY OF HELSINKI   (Finland)

^l NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^m VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ INSERM   (France)

^o UNIVERSITY OF CAPE TOWN   (South Africa)

^p KING SAUD UNIVERSITY   (Saudi Arabia)

more..

Author keywords

Association studies; Genetics; Ion channel; Long QT syndrome; Polymorphism; Risk factor

Indexed keywords

POTASSIUM CHANNEL KCNQ1;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; ELECTROCARDIOGRAM; FAINTNESS; FEMALE; FRANCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEART ARREST; HEART ARRHYTHMIA; HETEROZYGOTE; HUMAN; ITALY; JAPAN; LONG QT SYNDROME; LONG QT SYNDROME 1; LONG QT SYNDROME 2; MAJOR CLINICAL STUDY; MALE; MODIFIER GENE; PEDIGREE; PRIORITY JOURNAL; REPLICATION STUDY; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN CARDIAC DEATH;

ASSOCIATION STUDIES; GENETICS; ION CHANNEL; LONG-QT SYNDROME; POLYMORPHISM; RISK FACTOR;

ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; DATABASES, GENETIC; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMANS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84884514304     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.113.000023     Document Type: Article

References (39)

1. Schwartz P, Crotti L, Insolia R. Arrhythmogenic disorders of genetic origin: long QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol. 2012;5:868-873.
2. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992;327:846-852.
3. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 1999;99:529-533.
4. Schwartz PJ. Sudden cardiac death, founder populations, and mushrooms: what is the link with gold mines and modifier genes? Heart Rhythm. 2011;8:548-550.
5. Schwartz PJ, Vanoli E, Crotti L, Spazzolini C, Ferrandi C, Goosen A, et al. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. J Am Coll Cardiol. 2008;51:920-929.
6. Nishio Y, Makiyama T, Itoh H, Sakaguchi T, Ohno S, Gong YZ, et al. D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J Am Coll Cardiol. 2009;54:812-819.
7. Paavonen KJ, Swan H, Piippo K, Laitinen P, Fodstad H, Sarna S, et al. Beta1-Adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome. Int J Cardiol. 2007;118:197-202.
8. Crotti L, Monti MC, Insolia R, Peljto A, Goosen A, Brink PA, et al. NOS1AP is a genetic modifier of the long-QT syndrome. Circulation. 2009;120:1657-1663.
9. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866-1874.
10. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136-1144.
11. Newton-Cheh C, Larson MG, Corey DC, Benjamin EJ, Herbert AG, Levy D, et al. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: the Framingham Heart Study. Heart Rhythm. 2005;2:277-284.
12. Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet. 2006;38:644-651.
13. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K, et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet. 2009;41:399-406.
14. Pfeufer A, Sanna S, Arking DE, Müller M, Gateva V, Fuchsberger C, et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet. 2009;41:407-414.
15. Gouas L, Nicaud V, Chaouch S, Berthet M, Forhan A, Tichet J, et al. Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet. 2007;15:974-979.
16. Gouas L, Nicaud V, Berthet M, Forhan A, Tiret L, Balkau B, et al.; D.E.S.I.R. Study Group. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet. 2005;13:1213-1222.
17. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-Threatening arrhythmias. Circulation. 2001;103:89-95.
18. Laukkanen JA, Mäkikallio TH, Kauhanen J, Kurl S. Insertion/deletion polymorphism in alpha2-Adrenergic receptor gene is a genetic risk factor for sudden cardiac death. Am Heart J. 2009;158:615-621.
19. Brink PA, Crotti L, Corfield V, Goosen A, Durrheim G, Hedley P, et al. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation. 2005;112:2602-2610.
20. Fodstad H, Swan H, Laitinen P, Piippo K, Paavonen K, Viitasalo M, et al. Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Ann Med. 2004;36(Suppl 1):53-63.
21. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: an update. Circulation. 1993;88:782-784.
22. Vincent GM, Schwartz PJ, Denjoy I, Swan H, Bithell C, Spazzolini C, et al. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of betablocker treatment "failures." Circulation. 2009;119:215-221.
23. Brink PA, Schwartz PJ. Of founder populations, long QT syndrome, and destiny. Heart Rhythm. 2009;6(11 Suppl):S25-S33.
24. Peng B, Yu RK, Dehoff KL, Amos CI. Normalizing a large number of quantitative traits using empirical normal quantile transformation. BMC Proc. 2007;1(Suppl 1):S156.
25. Reardon M, Malik M. QT interval change with age in an overtly healthy older population. Clin Cardiol. 1996;19:949-952.
26. Yang H, Elko P, LeCarpentier GL, Baga J, Fromm B, Steinman RT, et al. Sex differences in the rate of cardiac repolarization. J Electrocardiol. 1994;27(Suppl):72-73.
27. Trégouët DA, Ducimetière P, Tiret L. Testing association between candidate-gene markers and phenotype in related individuals, by use of estimating equations. Am J Hum Genet. 1997;61:189-199.
28. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37:120-132.
29. Noseworthy PA, Havulinna AS, Porthan K, Lahtinen AM, Jula A, Karhunen PJ, et al. Common genetic variants, QT interval, and sudden cardiac death in a Finnish population-based study. Circ Cardiovasc Genet. 2011;4:305-311.
30. Holm H, Gudbjartsson DF, Arnar DO, Thorleifsson G, Thorgeirsson G, Stefansdottir H, et al. Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet. 2010;42:117-122.
31. Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, Bennaceur M, et al. KVLQT1 C-Terminal missense mutation causes a forme fruste long-QT syndrome. Circulation. 1997;96:2778-2781.
32. Crotti L, Spazzolini C, Schwartz PJ, Shimizu W, Denjoy I, Schulze-Bahr E, et al. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation. 2007;116:2366-2375.
33. Migdalovich D, Moss AJ, Lopes CM, Costa J, Ouellet G, Barsheshet A, et al. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-Threatening cardiac events in patients with long QT syndrome. Heart Rhythm. 2011;8:1537-1543.
34. Tomás M, Napolitano C, De Giuli L, Bloise R, Subirana I, Malovini A, et al. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. J Am Coll Cardiol. 2010;55:2745-2752.
35. Amin AS, Giudicessi JR, Tijsen AJ, Spanjaart AM, Reckman YJ, Klemens CA, et al. Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner. Eur Heart J. 2012;33:714-723.
36. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008;24:2938-2939.
37. Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M. Linking disease associations with regulatory information in the human genome. Genome Res. 2012;22:1748-1759.
38. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22:1790-1797.
39. Lahtinen AM, Marjamaa A, Swan H, Kontula K. KCNE1 D85N polymorphism -A sex-specific modifier in type 1 long QT syndrome? BMC Med Genet. 2011;12:11.